IHAM
Integral Health Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.44M | Hold |
200,000
| – | – | 0.86% | 33 |
|
|
2025
Q1 | $7.81M | Hold |
200,000
| – | – | 0.83% | 32 |
|
|
2024
Q4 | $10.8M | Sell |
200,000
-20,000
| -9% | -$1.08M | 0.92% | 38 |
|
|
2024
Q3 | $11.1M | Hold |
220,000
| – | – | 1.25% | 22 |
|
|
2024
Q2 | $9.67M | Hold |
220,000
| – | – | 0.92% | 33 |
|
|
2024
Q1 | $11.1M | Hold |
220,000
| – | – | 1.03% | 38 |
|
|
2023
Q4 | $13.3M | Sell |
220,000
-280,000
| -56% | -$16.9M | 1.81% | 17 |
|
|
2023
Q3 | $28.5M | Buy |
500,000
+200,000
| +67% | +$11.4M | 3.95% | 4 |
|
|
2023
Q2 | $15.3M | Buy |
+300,000
| New | +$15.3M | 1.89% | 11 |
|